Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BioNTech (BNTX) trades at $88.44, down 3.56% on the day, reflecting ongoing challenges as the company transitions from pandemic-era vaccine revenues to oncology-focused growth. The stock shows bearish technical signals with current price near support at $88, while fundamentals reveal significant losses with Q1 2026 net income of -$1.14B and negative profit margins. Recent corporate restructuring includes manufacturing site closures affecting 1,860 jobs and a $1B share buyback authorization announced May 2026, alongside promising oncology pipeline data presented at ASCO.
The outlook remains challenging with declining COVID revenues and substantial losses, though the company maintains a strong cash position of $16.78B to fund its oncology pipeline development. Investment opportunities center on potential success in late-stage cancer treatments, while risks include execution uncertainty in the therapeutic transition, continued earnings pressure, and competitive oncology landscape. Analyst consensus remains bullish with 87.5% buy ratings and $127.50 price target, suggesting significant upside if pipeline execution succeeds.
Read full analysis

Key Stats

  • Market Cap
    $22.54B
  • Sector
    Health
  • 3M Drawdown
    -21.34%
  • Enterprise Value
    $5.86B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    54 days
$88.39
52W Low: $83.89
10 Mar 2026
52W High: $119.34
27 Jan 2026

BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.54B, with an enterprise value of $5.86B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -21.34%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 54 days, indicating typical investor behavior on the platform.

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $22.54B
  • Sector
    Health
  • 3M Drawdown
    -21.34%
  • Enterprise Value
    $5.86B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    54 days
$88.39
52W Low: $83.89
10 Mar 2026
52W High: $119.34
27 Jan 2026

BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.54B, with an enterprise value of $5.86B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -21.34%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 54 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!